Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

PYPL

PayPal Holdings Inc

Jun 06 • 04:00PM ET

73.43

Dollar change +0.96
Percentage change 1.32	%

Financial • Credit Services • USA • NASD

Peers: MA V SOFI AXP DFS AFRM FIS GPN UPST INTU

| Held by: VTI VOO QQQ SPY IVV VTV XLF FDN QQQM QUAL

Index	NDX, S&P 500	P/E	16.47	EPS (ttm)	4.46	Insider Own	0.43%	Shs Outstand	979.00M	Perf Week	4.48%
Market Cap	71.41B	Forward P/E	12.99	EPS next Y	5.65	Insider Trans	-0.15%	Shs Float	968.31M	Perf Month	6.90%
Income	4.55B	PEG	1.46	EPS next Q	1.29	Inst Own	76.56%	Short Float	3.10%	Perf Quarter	4.19%
Sales	31.80B	P/S	2.25	EPS this Y	9.60%	Inst Trans	0.03%	Short Ratio	2.83	Perf Half Y	-13.75%
Book/sh	20.69	P/B	3.55	EPS next Y	10.95%	ROA	5.52%	Short Interest	30.00M	Perf Year	15.95%
Cash/sh	11.53	P/C	6.37	EPS next 5Y	11.28%	ROE	22.20%	52W Range	55.85 - 93.66	Perf YTD	-13.97%
Dividend Est.	-	P/FCF	11.97	EPS past 5Y	14.03%	ROI	14.08%	52W High	-21.60%	Beta	1.45
Dividend TTM	-	Quick Ratio	1.30	Sales past 5Y	12.64%	Gross Margin	41.24%	52W Low	31.48%	ATR (14)	1.72
Dividend Ex-Date	-	Current Ratio	1.30	EPS Y/Y TTM	12.82%	Oper. Margin	18.53%	RSI (14)	63.53	Volatility	1.07% 1.30%
Employees	24400	Debt/Eq	0.66	Sales Y/Y TTM	4.50%	Profit Margin	14.29%	Recom	2.37	Target Price	80.37
Option/Short	Yes / Yes	LT Debt/Eq	0.59	EPS Q/Q	55.52%	Payout	0.00%	Rel Volume	0.65	Prev Close	72.47
Sales Surprise	-0.74%	EPS Surprise	14.59%	Sales Q/Q	0.19%	Earnings	Apr 29 BMO	Avg Volume	10.59M	Price	73.43
SMA20	2.39%	SMA50	9.43%	SMA200	-4.20%	Trades		Volume	6,834,919	Change	1.32%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-02-25	Initiated	Truist	Sell	$68
Apr-23-25	Initiated	Compass Point	Sell	$56
Apr-17-25	Downgrade	Seaport Research Partners	Neutral → Sell	$49
Apr-14-25	Reiterated	BofA Securities	Buy	$103 → $93
Feb-28-25	Upgrade	DZ Bank	Hold → Buy	$92
Jan-06-25	Reiterated	Susquehanna	Positive	$94 → $101
Dec-17-24	Reiterated	Macquarie	Outperform	$95 → $115
Dec-13-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$107
Dec-09-24	Upgrade	BofA Securities	Neutral → Buy	$86 → $103
Nov-22-24	Resumed	Piper Sandler	Neutral	$88
Oct-28-24	Reiterated	Monness Crespi & Hardt	Buy	$95 → $110
Oct-14-24	Reiterated	Mizuho	Outperform	$90 → $100
Oct-10-24	Downgrade	Bernstein	Outperform → Mkt Perform	$75 → $80
Oct-01-24	Resumed	Oppenheimer	Perform
Aug-09-24	Upgrade	Daiwa Securities	Neutral → Outperform	$68 → $72
Jul-31-24	Upgrade	Bernstein	Mkt Perform → Outperform	$71 → $78
Jul-31-24	Upgrade	Argus	Hold → Buy
Jul-18-24	Downgrade	William Blair	Outperform → Mkt Perform
Jul-02-24	Upgrade	Susquehanna	Neutral → Positive	$71
Jun-24-24	Resumed	Goldman	Neutral	$69

Show Previous Ratings

Jun-06-25 12:47PM	AI Search Engine Perplexity Gains Traction vs. Google (GuruFocus.com)
12:43PM	Affirm Expands Global Footprint: Will It Deliver Sustainable Growth? (Zacks)
Jun-05-25 05:45PM	Paypal (PYPL) Stock Moves -0.45%: What You Should Know (Zacks)
05:28PM	Walmart, PayPal shareholders reject DEI overhauls as corporate America continues retreat from social issues (Yahoo Finance)
12:49PM	Mastercard's Expenses Are on the Rise: A Threat to Profit Margins? (Zacks)
11:30AM	Loading…
11:30AM	Fidelity National (FIS) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
08:53AM	Affirm Stock Moves Above 200-Day SMA: Time to Buy the Bounce? (Zacks)
07:48AM	3 Crypto-Centric Stocks in Focus on the Ongoing Bitcoin Rally (Zacks)
06:33AM	Mastercard and PayPal collaborate to ease checkout (Electronic Payments)
05:06AM	Jim Cramer Notes PayPal (PYPL)'s CEO Alex Chriss "Will Get You Where You Have to Go" (Insider Monkey)
Jun-04-25 11:34AM	Sezzle's Q1 Revenues Skyrocket 123%: What's Behind This Outcome? (Zacks)
11:16AM	PayPal's Venmo, Snowflake upgrade, Asana: Trending Tickers (Yahoo Finance Video)
10:35AM	PayPal, Klarna launch physical payment cards (Chain Store Age)
09:40AM	PayPal veteran named Bill CFO (CFO Dive)
09:40AM	Why Paypal (PYPL) is a Top Value Stock for the Long-Term (Zacks)
09:00AM	Loading…
09:00AM	Venmo Unleashes Next Phase of Commerce with the Venmo Debit Card and Venmo Checkout (PR Newswire)
08:31AM	Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle (Investing.com)
Jun-03-25 12:47PM	Chime's IPO terms show fintech valuations have returned to reality. That's a good thing. (MarketWatch)
09:28AM	Block Stock Catches an Upgrade. The Outlook Isn't as Bad as Feared. (Barrons.com)
09:00AM	PayPal Enhances Popular Online Credit Offering with New Physical Card for In-Store Use (PR Newswire)
Jun-02-25 02:48PM	Fintech Faces a Slowdown. Why Visa Stock Is One to Own While PayPal Isn't. (Barrons.com)
09:44AM	Boeing upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly)
May-29-25 11:30AM	Why Is Paypal (PYPL) Up 8.5% Since Last Earnings Report? (Zacks)
09:45AM	Why Paypal (PYPL) is a Top Growth Stock for the Long-Term (Zacks)
08:54AM	PayPal, Worldline secure approvals in India for cross-border payments (Electronic Payments)
06:58AM	PayPals venture arm taps new leader (Payments Dive)
May-28-25 06:14PM	2 Stocks Down 30% and 18% to Buy Hand Over Fist (Motley Fool)
11:28AM	Can Block's Expanding Merchant Network Push the XYZ Stock higher? (Zacks)
May-27-25 09:00AM	Investors Heavily Search PayPal Holdings, Inc. (PYPL): Here is What You Need to Know (Zacks)
08:49AM	3 Crypto-Centric Stocks in Focus as Bitcoin Resumes Its Rally (Zacks)
12:07PM	Loading…
May-26-25 12:07PM	PayPal Stock Trades 25% Below its 52-Week High: Buy, Sell or Hold? (Zacks)
09:54AM	PayPal (PYPL) Slid after a Strong 2024 (Insider Monkey)
May-24-25 04:30PM	Option traders moderately bearish in PayPal with shares down 2.23% (TipRanks)
May-23-25 08:50AM	Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day (Zacks)
May-22-25 11:22AM	3 Crypto-Centric Stocks to Watch as Bitcoin Hits All-Time High (Zacks)
09:50AM	Why Paypal (PYPL) is a Top Momentum Stock for the Long-Term (Zacks)
May-19-25 01:21PM	High-Yield ETFs: Big Payouts, Bigger Trade-Offs? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
07:35AM	PayPal brings Complete Payments Platform to Singapore (Electronic Payments)
May-18-25 05:30AM	The Smartest Fintech Stocks to Buy With $1,000 Right Now (Motley Fool)
May-16-25 12:23PM	PayPal vs. Block: Which Fintech Stock is a Stronger Buy Right Now? (Zacks)
10:43AM	Bitcoin on Track to Hit New High: 3 Crypto-Centric Stocks in Focus (Zacks)
09:00AM	Here is What to Know Beyond Why PayPal Holdings, Inc. (PYPL) is a Trending Stock (Zacks)
05:15AM	Blocks (XYZ) Square Resilence Shines Through Cash App Headwinds (TipRanks)
May-15-25 04:06PM	Ondo Finance enables 24/7 conversions between OUSG and PayPal USD (TheStreet)
03:38PM	PayPal Crypto Head Says Banks Are Needed to Unlock Full Stablecoin Potential (CoinDesk)
12:39PM	The invisible tech revolution poised to make in-chat AI shopping real (Fortune)
07:30AM	2 High Growth Buy Now, Pay Later Stocks Challenging PayPal (MarketBeat)
07:25AM	Perplexity, PayPal team up on agentic commerce (Electronic Payments)
05:17AM	PayPal Powers In-Chat Shopping on Perplexity (GuruFocus.com)
May-14-25 08:00PM	PayPal Complete Payments Launches for Singapore Businesses to Double Down on E-commerce Growth (PR Newswire)
04:06PM	Crypto and stock trading app eToro shares soar in Nasdaq debut: CNBC Crypto World (CNBC TV)
12:37PM	Perplexity, PayPal partner to provide easy payment checkouts to users (Reuters)
10:09AM	Affirm Swings Wildly Post Q3 Earnings: Is the Fintech Losing Steam? (Zacks)
08:00AM	Perplexity Selects PayPal to Power Agentic Commerce (PR Newswire)
07:34AM	PayPal (PYPL) Unleashes Agentic Commerce Following Benign SEC Probe and Solid Q1 (TipRanks)
May-13-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
04:40AM	2 Tech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
May-09-25 12:46PM	Squawk Pod: Leverage in the U.S. & China, Affirm CEO Max Levchin - 05/09/25 Audio Only (CNBC TV)
06:15AM	Is PayPal a Deep Value Stock or a Value Trap to Avoid? (Motley Fool)
May-08-25 08:12AM	PayPal and dLocal expand payments services in emerging markets (Electronic Payments)
May-07-25 11:13AM	PayPal Holdings, Inc. (PYPL): A Bull Case Theory (Insider Monkey)
05:48AM	PayPal: Strong Investment Setup (Seeking Alpha)
May-06-25 01:10PM	Should You Buy Affirm Stock Before its Q3 Earnings Release? (Zacks)
12:15PM	VC founder: Tariffs have triggered one big rethink on tech (Yahoo Finance)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:45AM	3 Growth Stocks With Incredible Upside Potential (Motley Fool)
08:21AM	PayPal to introduce contactless mobile wallet in Germany (Electronic Payments)
May-05-25 04:10PM	PayPal: Margins Are Improving, Strong Buy (Upgrade) (Seeking Alpha)
09:46AM	A Steady Business During Uncertain Times (Motley Fool)
09:00AM	Is Trending Stock PayPal Holdings, Inc. (PYPL) a Buy Now? (Zacks)
06:30AM	Better Growth Stock: PayPal vs. SoFi Technologies (Motley Fool)
May-04-25 06:15PM	Was Jim Cramer Right About PayPal (PYPL)? (Insider Monkey)
06:00AM	Here's How the Coinbase-PayPal Stablecoin Deal Could Rock Crypto (Motley Fool)
May-03-25 08:39PM	Should You Buy PayPal Stock Right Now? (Motley Fool)
10:16AM	SEC Closes PayPal PYUSD Probe As Rollback Of Gensler-Era Crypto Enforcement Barrage Continues (Benzinga)
06:47AM	What Moved Markets This Week (Seeking Alpha)
04:23AM	Does PayPal Stock Look Poised for a Turnaround? (Motley Fool)
01:47AM	Safe Haven In Uncertain Times, Year Three (Seeking Alpha)
May-02-25 04:15PM	Bitcoin trades above $97,000 following solid April jobs report: CNBC Crypto World (CNBC TV)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
06:15AM	Down 24% in 2025, Should You Buy This Cheap Stock and Hold for the Long Term? (Motley Fool)
05:52AM	PayPal: Strategies May Drive Long-Term Growth (Seeking Alpha)
May-01-25 03:54PM	ClearBridge Large Cap Growth ESG Portfolios Q1 2025 Commentary (Seeking Alpha)
03:47PM	SEC Ditches PayPal's PYUSD Probe, Removing Key Regulatory Hurdle for Its Stablecoin (CoinDesk)
10:03AM	PayPal veteran tapped as eBay's next CFO (Chain Store Age)
06:00AM	CEO of $41 Billion Payments Giant Swings Series of Megadeals in M&A Standstill (Bloomberg)
05:22AM	2 No-Brainer Fintech Stocks to Buy With $1,000 Right Now (Motley Fool)
12:09AM	PayPal: Earnings Are Mixed, Stock Is Still Very Cheap (Seeking Alpha)
Apr-30-25 02:47PM	PayPal Q1 Earnings: The Market Is Missing The Forest For The Trees (Seeking Alpha)
02:15PM	Visa CEO on economic slowdown, new stablecoin deal, and AI agents that shop for you (Yahoo Finance)
11:19AM	PayPal Holdings, Inc. (PYPL): Among Billionaire Cliff Asness' Stock Picks with Huge Upside Potential (Insider Monkey)
09:10AM	Company News for Apr 30, 2025 (Zacks)
09:00AM	Block: Falling Like Rain, But It's Time To Embrace The Pain (Seeking Alpha)
08:40AM	PayPal Looks Like One Of The Most Undervalued Stocks In The Market (Seeking Alpha)
08:15AM	Shift4 Payments Q1 Earnings: Capitalizing On Payment Tech Growth (Seeking Alpha)
07:33AM	PayPal Q1 net income climbs 45% (Electronic Payments)
07:05AM	Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul (Motley Fool)
04:24AM	PayPal Stock Earnings: Enough to Turn the Stock Around? (Motley Fool)
03:13AM	Is PayPal (PYPL) A Stock That Should Double in 3 Years? (Insider Monkey)

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MESSEMER DEBORAH M.	Director	Jun 06 '25	Sale	73.00	3,795	277,036	13,976	Jun 06 08:03 PM
DEBORAH M. MESSEMER	Director	Jun 06 '25	Proposed Sale	73.00	3,795	277,036		Jun 06 05:45 PM
DIEGO SCOTTI	Officer	Jun 06 '25	Proposed Sale	72.47	3,839	278,212		Jun 06 04:22 PM
SUZAN KEREERE	Officer	Jun 06 '25	Proposed Sale	72.47	4,162	301,620		Jun 06 04:22 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Jun 01 '25	Option Exercise	0.00	5,795	0	50,721	Jun 03 07:56 PM
Kereere Suzan	President, Global Markets	May 15 '25	Option Exercise	0.00	8,504	0	56,987	May 15 04:43 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Apr 15 '25	Option Exercise	0.00	19,985	0	55,979	Apr 16 08:25 PM
Scotti Diego	EVP, GM, Consumer Group	Apr 15 '25	Option Exercise	0.00	8,589	0	25,578	Apr 16 08:22 PM
Webster Aaron	EVP, Global Chief Risk Officer	Apr 15 '25	Option Exercise	0.00	65,565	0	65,565	Apr 16 08:18 PM
Chriss James Alexander	President and CEO	Apr 15 '25	Option Exercise	0.00	23,280	0	132,430	Apr 16 08:16 PM
Miller Jamie S	EVP, Chief Fin & Op Officer	Mar 15 '25	Option Exercise	0.00	12,007	0	35,513	Mar 18 04:49 PM
Gill Michelle	EVP, GM, SMB & Financial Svcs	Mar 15 '25	Option Exercise	0.00	12,007	0	36,218	Mar 18 04:49 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Mar 01 '25	Option Exercise	0.00	16,970	0	45,380	Mar 04 06:43 PM
MCGOVERN GAIL J	Director	Feb 27 '25	Sale	72.15	2,446	176,479	29,734	Feb 28 05:28 PM
MCGOVERN GAIL J	Director	Feb 27 '25	Proposed Sale	72.15	2,446	176,479		Feb 27 04:52 PM
Kereere Suzan	President, Global Markets	Feb 15 '25	Option Exercise	0.00	95,237	0	95,237	Feb 18 05:08 PM
Chriss James Alexander	President and CEO	Jan 15 '25	Option Exercise	0.00	23,280	0	121,343	Jan 17 05:33 PM
Scotti Diego	EVP, GM Consumer & Global Mkt	Jan 15 '25	Option Exercise	0.00	34,354	0	34,354	Jan 17 05:27 PM
Miller Jamie S	EVP, Chief Financial Officer	Dec 15 '24	Option Exercise	0.00	48,022	0	48,022	Dec 16 07:50 PM
Gill Michelle	EVP, GM, SMB & Financial Svcs	Dec 15 '24	Option Exercise	0.00	48,022	0	48,022	Dec 16 07:44 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Dec 01 '24	Option Exercise	0.00	3,296	0	30,046	Dec 02 04:39 PM
Chriss James Alexander	President and CEO	Oct 15 '24	Option Exercise	0.00	176,511	0	185,384	Oct 15 05:48 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Sep 01 '24	Option Exercise	0.00	3,296	0	28,386	Sep 03 07:34 PM

Dollar change +0.13
Percentage change 10.08	%

ALLO Allogene Therapeutics Inc daily Stock Chart

Peers: NTLA CRSP EDIT BEAM FDMT IOBT SGMO CLLS DTIL CYTK

| Held by: VTI IWM VXF IWN VTWO IBB SCHA VHT DFAC DFAS

Index	RUT	P/E	-	EPS (ttm)	-1.23	Insider Own	31.67%	Shs Outstand	218.60M	Perf Week	21.37%
Market Cap	310.60M	Forward P/E	-	EPS next Y	-0.99	Insider Trans	-0.30%	Shs Float	149.47M	Perf Month	18.33%
Income	-252.32M	PEG	-	EPS next Q	-0.27	Inst Own	66.00%	Short Float	18.31%	Perf Quarter	-34.86%
Sales	0.00M	P/S	-	EPS this Y	23.60%	Inst Trans	7.00%	Short Ratio	8.16	Perf Half Y	-38.66%
Book/sh	1.76	P/B	0.81	EPS next Y	2.31%	ROA	-46.11%	Short Interest	27.36M	Perf Year	-39.06%
Cash/sh	1.28	P/C	1.11	EPS next 5Y	7.02%	ROE	-59.60%	52W Range	0.86 - 3.78	Perf YTD	-33.33%
Dividend Est.	-	P/FCF	-	EPS past 5Y	6.26%	ROI	-54.07%	52W High	-62.43%	Beta	0.30
Dividend TTM	-	Quick Ratio	9.71	Sales past 5Y	-	Gross Margin	-	52W Low	64.71%	ATR (14)	0.12
Dividend Ex-Date	-	Current Ratio	9.71	EPS Y/Y TTM	31.43%	Oper. Margin	-	RSI (14)	59.54	Volatility	6.30% 6.53%
Employees	229	Debt/Eq	0.23	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.36	Target Price	8.15
Option/Short	Yes / Yes	LT Debt/Eq	0.21	EPS Q/Q	27.82%	Payout	-	Rel Volume	1.03	Prev Close	1.29
Sales Surprise	-100.00%	EPS Surprise	3.61%	Sales Q/Q	-100.00%	Earnings	May 13 AMC	Avg Volume	3.35M	Price	1.42
SMA20	21.82%	SMA50	5.21%	SMA200	-31.11%	Trades		Volume	3,470,395	Change	10.08%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Mar-14-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$5
Aug-08-24	Resumed	Oppenheimer	Outperform	$13 → $11
May-31-24	Initiated	Piper Sandler	Overweight	$11
Jan-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-05-24	Downgrade	Guggenheim	Buy → Neutral
Dec-08-23	Initiated	Citigroup	Buy	$7
Dec-08-23	Initiated	Citigroup	Buy
Jun-26-23	Resumed	Oppenheimer	Outperform	$28
Mar-21-23	Initiated	Bernstein	Mkt Perform	$6
Jan-24-23	Upgrade	JP Morgan	Neutral → Overweight	$20 → $11
Jan-06-23	Upgrade	Robert W. Baird	Neutral → Outperform	$12
Dec-12-22	Downgrade	BofA Securities	Buy → Underperform	$24 → $9
Aug-10-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-15-22	Upgrade	Goldman	Neutral → Buy	$9 → $32
Jun-03-22	Initiated	Robert W. Baird	Neutral	$11
Feb-28-22	Reiterated	B. Riley Securities	Buy	$30 → $21
Oct-20-21	Initiated	Cowen	Outperform
Oct-08-21	Downgrade	Stifel	Buy → Hold	$44 → $18
Oct-08-21	Downgrade	Goldman	Buy → Neutral	$71 → $20

Show Previous Ratings

Jun-04-25 12:00PM	All You Need to Know About Allogene Therapeutics (ALLO) Rating Upgrade to Buy (Zacks)
Jun-01-25 10:45AM	Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO (GlobeNewswire)
May-23-25 08:30AM	Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
May-22-25 05:17PM	Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel (GlobeNewswire)
May-20-25 09:11AM	REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research (Zacks) +6.42%
06:36AM	Loading…
May-16-25 06:36AM	Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff (BioPharma Dive)
May-15-25 11:04AM	Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus (Zacks) +14.40%
09:43AM	Allogene (ALLO) Sinks 16% on Downgrade, Trial Delays (GuruFocus.com)
09:35AM	Allogene Therapeutics (ALLO) Loses -31.94% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
May-14-25 11:41AM	Fate Therapeutics' Q1 Earnings & Revenues Beat, Pipeline in Focus (Zacks) -15.68%
10:46AM	Q1 2025 Allogene Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
09:00AM	EXEL Q1 Earnings Beat, 2025 Sales View Up as Cabometyx Drives Top Line (Zacks)
06:29AM	Allogene's Q1 Earnings In Line With Estimates, Sales Nil (Zacks)
03:18AM	Allogene Therapeutics Inc (ALLO) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
May-13-25 04:11PM	Allogene Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update (GlobeNewswire)
12:07PM	Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks)
08:42AM	Editas Q1 Loss Narrower Than Expected, Revenues Increase Y/Y (Zacks)
May-12-25 09:40AM	Allogene Therapeutics Inc (ALLO) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
09:20AM	RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up (Zacks)
May-09-25 08:26AM	Is Allogene Therapeutics, Inc. (ALLO) the Low Risk High Reward Stock Set to Triple by 2030? (Insider Monkey)
May-06-25 08:30AM	Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update (GlobeNewswire) -20.99%
Apr-23-25 10:12AM	Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-08-25 06:46AM	FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug (Zacks)
Apr-07-25 08:30AM	Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma (GlobeNewswire)
Mar-30-25 03:50AM	abrdn Life Sciences Investors Q4 2024 Commentary (Seeking Alpha)
Mar-14-25 03:00PM	Allogene Therapeutics Inc (ALLO) Q4 2024 Earnings Call Highlights: Financial Challenges Amid ... (GuruFocus.com)
Mar-13-25 04:11PM	Allogene Therapeutics: Q4 Earnings Snapshot (Associated Press Finance) -8.25%
04:02PM	Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update (GlobeNewswire)
Mar-03-25 08:30AM	Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update (GlobeNewswire) -7.69%
08:30AM	Loading…
Feb-26-25 08:30AM	Allogene Therapeutics Announces Participation in March Investor Conference (GlobeNewswire)
Feb-25-25 04:10PM	Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia (GlobeNewswire) -7.24%
Feb-13-25 04:30PM	Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology (GlobeNewswire) +44.68%
Feb-04-25 08:30AM	Allogene Therapeutics Announces Participation in February Investor Conferences (GlobeNewswire)
Jan-29-25 08:30AM	Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer (GlobeNewswire)
Jan-28-25 08:30AM	Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases (GlobeNewswire)
Dec-26-24 12:00PM	Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
11:26AM	Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment (PR Newswire)
Dec-16-24 08:30AM	Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +8.99%
Dec-12-24 08:30AM	Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman (GlobeNewswire) -5.61%
Nov-25-24 12:00PM	Allogene Therapeutics (ALLO) Upgraded to Buy: Here's Why (Zacks)
Nov-19-24 08:30AM	Allogene Therapeutics Announces Participation in December Investor Conferences (GlobeNewswire)
Nov-18-24 08:30AM	Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence (GlobeNewswire) -5.29%
Nov-08-24 06:07AM	Allogene Therapeutics Inc (ALLO) Q3 2024 Earnings Call Highlights: Financial Resilience Amidst ... (GuruFocus.com)
Nov-07-24 04:11PM	Allogene Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update (GlobeNewswire)
10:00AM	Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS (GlobeNewswire)
Nov-06-24 07:31AM	Allogene Therapeutics Inc (ALLO) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +7.69%
Nov-05-24 09:10AM	Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive Advanced Renal Cell Carcinoma (RCC) at the International Kidney Cancer Symposium (IKCS) and Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Nov-04-24 08:30AM	Allogene Therapeutics Announces Participation in November Investor Conferences (GlobeNewswire) +10.29%
Oct-31-24 10:01AM	Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-30-24 08:30AM	Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update (GlobeNewswire) -5.71%
Oct-29-24 08:30AM	Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC) (GlobeNewswire)
Oct-22-24 04:05PM	Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors (GlobeNewswire)
Oct-03-24 07:19AM	Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In Now (Insider Monkey)
Sep-30-24 08:30AM	Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference (GlobeNewswire)
Sep-26-24 08:30AM	Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence (GlobeNewswire)
Sep-14-24 05:39PM	Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This Cancer Stock (Insider Monkey)
Sep-06-24 11:31AM	Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-08-24 09:50AM	Allogene (ALLO) Posts Narrower Than Expected Loss in Q2 (Zacks)
08:30AM	Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
06:00AM	7 Biotech Stocks to Buy for Their Game-Changing Potential (InvestorPlace)
Aug-07-24 04:10PM	Allogene Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update (GlobeNewswire)
Jul-31-24 08:30AM	Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update (GlobeNewswire)
Jul-01-24 08:30AM	Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) (GlobeNewswire)
Jun-27-24 10:13AM	Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock? (Insider Monkey)
Jun-26-24 04:36PM	Top 10 Small-Cap Stocks with Highest Upside Potential (Insider Monkey)
Jun-20-24 08:30AM	Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse (GlobeNewswire) +9.42%
Jun-12-24 11:30AM	Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound? (Zacks)
May-29-24 08:55AM	Insiders Pour Millions Into These 2 Strong Buy Stocks (TipRanks)
May-28-24 04:05PM	If You Can Only Buy One Penny Stock in May, It Better Be One of These 3 Names (InvestorPlace)
May-23-24 08:30AM	Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit (GlobeNewswire)
May-21-24 01:56PM	Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More (Insider Monkey)
08:16AM	Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating (MT Newswires)
May-16-24 08:13AM	HC Wainwright Adjusts Price Target on Allogene Therapeutics to $9 From $10, Keeps Buy Rating (MT Newswires)
May-14-24 12:56PM	Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag (Zacks)
09:14AM	Stifel Adjusts Price Target on Allogene Therapeutics to $4.60 From $4.40, Keeps Hold Rating (MT Newswires)
08:21AM	B. Riley Adjusts Price Target on Allogene Therapeutics to $7 From $10, Keeps Buy Rating (MT Newswires)
03:06AM	Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 08:55PM	ALLO Stock Earnings: Allogene Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.07%
05:36PM	Allogene Therapeutics Prices $110 Million Offering (MT Newswires)
05:10PM	Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:47PM	Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock (GlobeNewswire)
04:17PM	Allogene Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:14PM	Allogene Therapeutics Q1 Loss Narrows, Revenue Declines (MT Newswires)
04:01PM	Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update (GlobeNewswire)
May-06-24 08:30AM	Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update (GlobeNewswire)
Apr-26-24 10:32AM	Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development (MT Newswires)
08:30AM	Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma (GlobeNewswire)
Apr-24-24 10:01AM	Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -9.79%
Apr-11-24 02:45PM	3 Meme Stocks to Sell and Replace With Meme Coins (InvestorPlace)
Apr-09-24 08:30AM	Allogene Therapeutics Announces Q2 Investor Conference Participation (GlobeNewswire)
Apr-08-24 08:46AM	How Allogene (ALLO) Stock Stands Out in a Strong Industry (Zacks)
Mar-16-24 04:35PM	Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-15-24 09:32AM	Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss (Zacks)
07:04AM	Q4 2023 Allogene Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	ALLO Stock Earnings: Allogene Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -7.89%
05:34PM	Allogene Therapeutics Inc (ALLO) Reports Q4 and Full Year 2023 Financials, Forecasts Cash ... (GuruFocus.com)
05:15PM	Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yoshiyama Annie	SVP, Finance	Apr 21 '25	Sale	1.41	9,601	13,537	130,663	Apr 23 05:28 PM
Yoshiyama Annie	Officer	Apr 21 '25	Proposed Sale	1.41	9,601	13,537		Apr 21 04:49 PM
Chang David D	President and CEO	Mar 14 '25	Sale	1.96	46,668	91,469	5,276,569	Mar 18 05:30 PM
Beneski Benjamin Machinas	SVP, Chief Technical Officer	Mar 14 '25	Sale	1.98	5,488	10,839	218,507	Mar 18 05:28 PM
Beneski Benjamin Machinas	Officer	Mar 14 '25	Proposed Sale	1.97	5,488	10,839		Mar 14 04:58 PM
Chang David D	Officer	Mar 14 '25	Proposed Sale	1.96	46,668	91,469		Mar 14 04:57 PM
MESSEMER DEBORAH M.	Director	Feb 18 '25	Sale	2.43	13,313	32,351	144,316	Feb 20 04:15 PM
MESSEMER DEBORAH M.	Director	Feb 18 '25	Proposed Sale	2.43	13,313	32,329		Feb 18 05:27 PM
Douglas Earl Martin	SVP, General Counsel	Feb 03 '25	Sale	1.71	6,404	10,951	587,848	Feb 05 04:16 PM
Parker Geoffrey M.	CHIEF FINANCIAL OFFICER	Feb 03 '25	Sale	1.73	4,361	7,545	1,301,540	Feb 05 04:15 PM
MOORE TIMOTHY L.	Chief Technical Officer	Feb 03 '25	Sale	1.71	14,746	25,216	250,713	Feb 05 04:14 PM
Chang David D	President and CEO	Feb 03 '25	Sale	1.68	46,003	77,285	5,317,237	Feb 05 04:13 PM
Roberts Zachary	EVP of R&D	Feb 03 '25	Sale	1.70	18,832	32,014	643,135	Feb 05 04:12 PM
Roberts Zachary	Officer	Feb 03 '25	Proposed Sale	1.70	18,832	32,014		Feb 03 04:32 PM
Chang David D	Officer	Feb 03 '25	Proposed Sale	1.68	46,003	77,446		Feb 03 04:31 PM
Douglas Earl Martin	Officer	Feb 03 '25	Proposed Sale	1.71	6,404	10,951		Feb 03 04:30 PM
MOORE TIMOTHY L.	Officer	Feb 03 '25	Proposed Sale	1.71	14,746	25,225		Feb 03 04:29 PM
Parker Geoffrey M.	Officer	Feb 03 '25	Proposed Sale	1.73	4,361	7,545		Feb 03 04:28 PM
Roberts Zachary	EVP of R&D	Jan 21 '25	Sale	1.78	27,199	48,414	488,054	Jan 23 04:30 PM
Roberts Zachary	Officer	Jan 21 '25	Proposed Sale	1.78	27,199	48,499		Jan 21 04:22 PM
MESSEMER DEBORAH M.	Director	Dec 09 '24	Sale	2.18	9,136	19,916	157,629	Dec 10 04:53 PM
Humer Franz B	Director	Dec 05 '24	Sale	2.16	9,221	19,917	307,507	Dec 09 04:05 PM
MESSEMER DEBORAH M.	Director	Dec 09 '24	Proposed Sale	2.18	9,136	19,954		Dec 09 04:02 PM
Humer Franz B	Director	Dec 03 '24	Proposed Sale	2.48	9,221	22,868		Dec 02 02:11 PM
Parker Geoffrey M.	Officer	Oct 21 '24	Proposed Sale	2.84	36,404	103,501		Oct 21 04:05 PM
Douglas Earl Martin	Officer	Aug 21 '24	Proposed Sale	2.79	28,310	78,844		Aug 21 04:18 PM
MESSEMER DEBORAH M.	Director	Jun 18 '24	Sale	2.28	18,641	42,488	166,765	Jun 20 04:31 PM

Open in Screener

TPG

TPG Inc

Jun 06 • 04:00PM ET

50.25

Dollar change +1.34
Percentage change 2.74	%

Financial • Asset Management • USA • NASD

Peers: BX KKR CG APO ARES HLNE BXMT MAIN OCSL GAIN

| Held by: VTI VB VBR VXF FDVV SCHA IWR VYM PSP IWD

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	7.05%	Shs Outstand	137.99M	Perf Week	4.40%
Market Cap	18.57B	Forward P/E	17.49	EPS next Y	2.87	Insider Trans	-44.64%	Shs Float	128.26M	Perf Month	8.63%
Income	1.82M	PEG	-	EPS next Q	0.44	Inst Own	73.17%	Short Float	5.59%	Perf Quarter	2.38%
Sales	3.71B	P/S	5.01	EPS this Y	-1.18%	Inst Trans	4.10%	Short Ratio	3.58	Perf Half Y	-27.41%
Book/sh	6.66	P/B	7.54	EPS next Y	41.85%	ROA	0.02%	Short Interest	7.16M	Perf Year	23.77%
Cash/sh	2.26	P/C	22.23	EPS next 5Y	19.72%	ROE	0.24%	52W Range	37.52 - 72.98	Perf YTD	-20.04%
Dividend Est.	1.84 (3.65%)	P/FCF	-	EPS past 5Y	-	ROI	0.06%	52W High	-31.15%	Beta	1.53
Dividend TTM	1.74 (3.46%)	Quick Ratio	1.24	Sales past 5Y	11.97%	Gross Margin	96.39%	52W Low	33.93%	ATR (14)	1.63
Dividend Ex-Date	May 19, 2025	Current Ratio	1.24	EPS Y/Y TTM	-99.64%	Oper. Margin	2.82%	RSI (14)	58.06	Volatility	1.20% 2.34%
Employees	1900	Debt/Eq	2.55	Sales Y/Y TTM	44.23%	Profit Margin	0.05%	Recom	2.23	Target Price	53.08
Option/Short	Yes / Yes	LT Debt/Eq	2.51	EPS Q/Q	103.51%	Payout	-	Rel Volume	0.86	Prev Close	48.91
Sales Surprise	0.27%	EPS Surprise	4.92%	Sales Q/Q	25.14%	Earnings	May 07 BMO	Avg Volume	2.00M	Price	50.25
SMA20	1.51%	SMA50	6.79%	SMA200	-12.27%	Trades		Volume	1,713,224	Change	2.74%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-14-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$47
Sep-12-24	Initiated	Wells Fargo	Overweight	$60
May-10-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$43 → $52
Jan-04-24	Initiated	TD Cowen	Market Perform	$38
Dec-06-23	Resumed	BMO Capital Markets	Market Perform	$36
Nov-30-23	Resumed	Goldman	Buy	$43
May-19-23	Initiated	Citigroup	Buy	$32
Jan-24-23	Downgrade	JP Morgan	Overweight → Neutral	$35 → $34
Oct-19-22	Initiated	Credit Suisse	Neutral	$27.50
Oct-17-22	Initiated	Jefferies	Hold	$30
Oct-14-22	Downgrade	Exane BNP Paribas	Outperform → Neutral	$32
Jun-08-22	Initiated	JMP Securities	Mkt Perform

Show Previous Ratings

Jun-05-25 08:34AM	TPG co-founder Jim Coulter: Uncertainty creates pause in private markets (CNBC TV)
May-28-25 08:30AM	TPG to Present at the Morgan Stanley U.S. Financials Conference (Business Wire)
May-27-25 05:22PM	S&P 500 Gains and Losses Today: Index Rises After Trump Extends EU Tariff Deadline (Investopedia)
May-20-25 08:50PM	TPG Announces Pricing of Secondary Public Offering (Business Wire) -5.27%
04:12PM	TPG Announces Launch of Secondary Public Offering (Business Wire)
02:10PM	Loading…
May-07-25 02:10PM	TPG Inc. (TPG) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha)
09:15AM	TPG Inc. (TPG) Q1 Earnings Lag Estimates (Zacks)
08:00AM	TPG Reports First Quarter 2025 Results (Business Wire)
May-06-25 04:53PM	AvidXchange Agrees to be Acquired by TPG in Partnership with Corpay for $2.2 Billion (GlobeNewswire)
04:30PM	TPG to Acquire Peppertree Capital Management (Business Wire)
May-05-25 05:55PM	Great Elm Capital (GECC) Tops Q1 Earnings and Revenue Estimates (Zacks)
May-02-25 01:15PM	Masters Champion Rory McIlroy on teaming up with TPG (CNBC TV)
10:14AM	Rory McIlroy on launch of TPG Sports, investing in sports and Masters win (CNBC TV)
08:12AM	Rory McIlroy teams up with TPG (CNBC TV)
May-01-25 10:01AM	Victory Capital Holdings (VCTR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:00AM	Loading…
09:00AM	TPG Launches Dedicated Sports Investing Business (Business Wire)
Apr-30-25 10:01AM	TPG Inc. (TPG) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-29-25 06:20PM	TPG RE Finance Trust, Inc. Reports Operating Results for the Quarter Ended March 31, 2025 (Business Wire)
Apr-28-25 10:25AM	Sabre to Sell Hospitality Solutions Business to TPG for $1.1 Billion (The Wall Street Journal)
08:55AM	Sabre enters into definitive agreement to sell its Hospitality Solutions business unit to TPG for $1.1 billion (PR Newswire)
Apr-24-25 06:14PM	TimesSquare U.S. Focus Growth Q1 2025 Commentary (Seeking Alpha)
02:50PM	TimesSquare U.S. Mid Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-22-25 03:28PM	Sales volumes and demand will be important to watch in Tesla earnings, says former Ford CEO (CNBC TV)
10:22AM	TPG Inc. (TPG): Among Small Cap Financial Stocks Hedge Funds Are Buying (Insider Monkey)
Apr-21-25 08:30AM	TPG and Temasek Join TA to Bolster Cliffwaters Continued Expansion (Business Wire)
Apr-17-25 10:50PM	East 72 Dynasty Trust Q1 2025 Quarterly Report (Seeking Alpha)
Apr-16-25 04:10PM	TPG RE Finance Trust, Inc. Announces First Quarter 2025 Earnings Release and Conference Call Dates (Business Wire)
Apr-15-25 09:05AM	Here's Why Vulcan Value Partners Purchased TPG (TPG) (Insider Monkey)
Apr-11-25 08:00AM	TPG to Announce First Quarter 2025 Financial Results and Host Investor Call (Business Wire)
Apr-10-25 09:14AM	TPG Inc. (TPG) Soars 15.6%: Is Further Upside Left in the Stock? (Zacks)
06:15AM	Loading…
06:15AM	Vulcan Value Partners Q1 2025 Letter (Seeking Alpha)
Apr-07-25 08:07AM	Is TPG (TPG) Positioned to Benefit from Surging Demand for Illiquid Alternative Investments? (Insider Monkey)
Mar-31-25 07:00AM	TPG RE Finance Trust, Inc. Closes $1.1 Billion Commercial Real Estate CLO (Business Wire)
Mar-27-25 04:00AM	Private Equity Shifts Focus To Fossil Fuels From Renewables (SeekingAlpha)
Mar-17-25 04:30PM	TPG Names Jennifer Chu as Chief Legal Officer and General Counsel (Business Wire)
Mar-07-25 04:59PM	TPG Inc. (TPG) Partners with Broadvoice to Enhance AI-Powered Quality Assurance (Insider Monkey) -5.26%
Mar-05-25 10:25AM	Warburg Pincus Partners With Hassana to Chase Saudi Arabia Deals (Bloomberg)
Feb-12-25 02:11AM	TPG Inc (TPG) Q4 2024 Earnings Call Highlights: Record Distributable Earnings and Strategic ... (GuruFocus.com)
Feb-11-25 08:00AM	TPG Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-10-25 07:10AM	TPG Inc (TPG) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jan-30-25 08:00AM	TPG to Present at the BofA Securities 2025 Financial Services Conference (Business Wire)
Jan-15-25 04:15PM	TPG Appoints Kathy Elsesser as New Independent Director (Business Wire)
08:00AM	TPG to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Investor Call (Business Wire)
Jan-10-25 10:00AM	Venu Sports the proposed sports streaming venture between ESPN, Fox, and Warner Bros. is no more (Yahoo Finance)
Dec-23-24 04:21PM	TPG reportedly in talks to acquire Altus Power: Reuters (Yahoo Finance Video)
Dec-13-24 04:15PM	TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock (Business Wire)
Dec-12-24 09:00AM	Climate Tech Funds See Cash Pile Rise to $86 Billion as Investing Slows (Bloomberg)
Dec-11-24 02:40PM	David Bonderman, Private Equity Founder, Dead at 82 (The Wall Street Journal)
Dec-09-24 09:24AM	Heres What Lifted TPG (TPG) By 40% (Insider Monkey)
Dec-06-24 04:15PM	TPG RE Finance Trust, Inc. Declares Cash Dividend on Series C Cumulative Redeemable Preferred Stock (Business Wire)
Dec-03-24 08:55AM	AT&T Outlines Strategy Pledging Over $40B in Buybacks, Dividends (Investopedia)
Nov-29-24 04:12AM	TPG on Verge of Buying Controlling Stake in Asian Flower Business Hasfarm (Bloomberg)
Nov-25-24 08:00AM	TPG to Present at the Goldman Sachs 2024 U.S. Financial Services Conference (Business Wire)
Nov-22-24 07:54AM	5 Things to Know Before the Stock Market Opens (Investopedia)
06:11AM	DirecTV Scraps Dish Acquisition as Bondholders Push Back on Satellite-TV Merger (Investopedia)
Nov-13-24 08:00AM	Demopolis Equity Partners Announces Strategic Partnership with TPG (Business Wire)
Nov-12-24 06:42AM	TPG price target raised to $69 from $67 at Deutsche Bank (TipRanks)
Nov-06-24 06:35AM	TPG price target raised to $68 from $67 at Wells Fargo (TipRanks) +11.35%
Nov-04-24 08:00AM	TPG Reports Third Quarter 2024 Results (Business Wire) -6.29%
Oct-29-24 03:38PM	Hilco, TPG in joint venture to acquire struggling retail brands, beginning with... (Chain Store Age)
Oct-24-24 12:00AM	Vinted Secures TPG-Led Secondary Investment at Valuation of 5B, Reflecting Profitable Growth (PR Newswire)
Oct-21-24 03:00PM	TPG Names Recently Established Entertainment Company Initial Group and Acquires Grandview in Partnership with Untitled Entertainment (Business Wire)
Oct-14-24 11:38AM	Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid (Investopedia)
Oct-07-24 08:00AM	TPG to Announce Third Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Sep-30-24 04:22PM	DirecTV and Dish have spent years trying to merge. It's finally happening. (Yahoo Finance)
04:01PM	DirecTV To Merge With Dish Network As AT&T Exits Pay-TV Business (Investor's Business Daily)
09:30AM	Creative Planning Announces Strategic Investment from TPG Capital (Business Wire)
08:44AM	Satellite Rivals DirecTV, Dish To Merge (Investopedia)
07:53AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:46AM	DirecTV and Dish have spent years trying to merge. It might finally happen. (Yahoo Finance)
07:00AM	DIRECTV to Acquire EchoStar's Video Distribution Business, Including DISH TV and Sling TV (PR Newswire)
06:55AM	Satellite service DirecTV buys rival Dish as it fights the onslaught of streaming services (Associated Press Finance)
06:13AM	TPG to Acquire AT&T's 70% Stake in DIRECTV (Business Wire)
Sep-27-24 01:44PM	EchoStar Stock Soars on Report Dish Close To Merging With DirecTV (Investopedia)
10:00AM	DirecTV, Dish reportedly close to merger deal: BBG (Yahoo Finance Video)
07:00AM	Why Drug Distributors Are Buying Cancer Specialists (The Wall Street Journal)
Sep-26-24 05:00PM	Homrich Berg Announces New Minority Investment Partner TPG Growth (Business Wire)
Sep-16-24 09:05PM	TPG Angelo Gordon, Dream Unlimited Corp., and Stadium Capital Partners to Acquire Dutch Residential Real Estate Portfolio (Business Wire)
Sep-11-24 07:55AM	Douglas Dynamics Completes $64.2 Million Sale-Leaseback Transaction with TPG Angelo Gordon (GlobeNewswire)
Sep-06-24 03:08PM	Bondermans Wildcat Spawns New Hedge Fund, Invests $200 Million (Bloomberg)
Sep-03-24 04:20PM	Sixth Street Buys TPG Partners Stake at $10 Billion Value (Bloomberg)
04:05PM	TPG to Present at the Barclays Global Financial Services Conference (Business Wire)
Aug-23-24 05:46AM	Oaktree Plans to Seek Partner for 3,800 Home Project in Dublin (Bloomberg)
Aug-22-24 09:00AM	TPG-Backed PS to be Acquired by Groupe ADP (Business Wire)
Aug-15-24 01:00AM	EQT Seeks $12.5 Billion for Next Asia Fund, Defying Gloom (Bloomberg)
Aug-06-24 03:39PM	TPG Points to Deal Acceleration Heading Into the Second Half (The Wall Street Journal)
08:00AM	TPG Reports Second Quarter 2024 Results (Business Wire)
Jul-18-24 12:06AM	Director Deborah Messemer Sells 4,089 Shares of TPG Inc (TPG) (GuruFocus.com)
Jul-16-24 04:49AM	Strength Seen in TPG Inc. (TPG): Can Its 5.1% Jump Turn into More Strength? (Zacks)
Jul-10-24 08:00AM	TPG to Announce Second Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Jul-04-24 12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
Jun-28-24 08:00AM	TPG Establishes New Talent Management and Representation Company to Invest in and Build a Scaled Talent-Centric Business (Business Wire)
07:55AM	BOAT ROCKER SELLS MAJORITY STAKE IN UNTITLED ENTERTAINMENT TO LEADING GLOBAL ALTERNATIVE ASSET MANAGER TPG (PR Newswire)
Jun-17-24 09:30AM	K2 Medical Research and TPG Establish Partnership to Build a Leading Integrated Site Platform (Business Wire)
Jun-08-24 05:30PM	15 Most Advanced Countries in 5G Technology (Insider Monkey)
May-29-24 08:00AM	TPG to Present at the Morgan Stanley U.S. Financials, Payments & CRE Conference (Business Wire)
May-22-24 08:07AM	Full Truck Alliance Co. Ltd. (NYSE:YMM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 12:54PM	TPG Stock Earnings: TPG Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:25AM	TPG Inc. (TPG) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	TPG Reports First Quarter 2024 Results (Business Wire)

TPG, Inc. operates as a global, diversified alternative asset management firm. It invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions. The firm aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment strategy and performance of its portfolio. The company was founded by Jim Coulter and David Bonderman in 1992 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Holloway Samantha	Former 10% Owner	May 22 '25	Sale	46.57	21,000,000	977,970,000	0	May 27 04:44 PM
Berenson Bradford	General Counsel	Mar 19 '25	Sale	50.04	2,509	125,558	290,841	Mar 21 04:37 PM
Berenson Bradford	General Counsel	Mar 05 '25	Sale	50.32	2,598	130,721	293,350	Mar 07 04:19 PM
Bradford Berenson	General Counsel	Mar 05 '25	Proposed Sale	50.83	17,652	897,251		Mar 05 05:24 PM
MESSEMER DEBORAH M.	Director	Jan 14 '25	Sale	61.91	1,695	104,931	15,841	Jan 15 05:36 PM
DEBORAH M. MESSEMER	Director	Jan 14 '25	Proposed Sale	61.88	1,695	104,887		Jan 14 04:19 PM
LEGAG Partners LLC	Stockholder	Nov 15 '24	Proposed Sale	65.90	299,992	19,769,473		Nov 15 04:24 PM
MESSEMER DEBORAH M.	Director	Jul 17 '24	Sale	46.55	4,089	190,332	17,536	Jul 17 05:37 PM

PYPL

PayPal Holdings Inc

ALLO

Allogene Therapeutics Inc

TPG

TPG Inc

Upgrade your FINVIZ experience